logo
Select company
Select metric
-18.08%Free Cash Flow to Operating Cash Flow
VS
Market
10
Sector
6
Industry
13
History
14
$ 9.17Close
$ 8.1 - $ 25.15 52-Week Range
Ticker Information

Ticker

ANIK

Company Name

ANIKA THERAPEUTICS INC

Sector

Healthcare

Industry

Medical Devices

Exchange

NASDAQ

ANIKA THERAPEUTICS INC - Free Cash Flow to Operating Cash Flow Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

ANIK - FCF/OCF Historical data
DateFree Cash FlowFree Cash Flow to Operating Cash FlowNet Cash Flow - Operations
6/30/2025$ -1.14M-18.08%$ 6.28M
3/31/2025$ -3.95M-73.18%$ 5.4M
12/31/2024$ -2.93M-54.25%$ 5.4M
9/30/2024$ -808K-10.83%$ 7.46M
6/30/2024$ 1.14M12.72%$ 8.93M
3/31/2024$ -4.14M-243.08%$ 1.7M
12/31/2023$ -7.21M0%$ -1.79M
9/30/2023$ -11.06M0%$ -4.95M
6/30/2023$ -15.79M0%$ -8.72M
3/31/2023$ -4.89M-183.8%$ 2.66M
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • ANIKA THERAPEUTICS INC's latest trailing twelve months (TTM) FCF/OCF stands at 93.84%.
  • Over the past 5 years, ANIKA THERAPEUTICS INC's average FCF/OCF has been -8.77%.
  • The median FCF/OCF for ANIKA THERAPEUTICS INC during this period was 26.78%
  • ANIKA THERAPEUTICS INC reached its highest FCF/OCF over the past 5 years at 93.84%.
  • The lowest FCF/OCF recorded by ANIKA THERAPEUTICS INC in the same timeframe -243.08%

ANIKA THERAPEUTICS INC's FCF/OCF vs. competitors

We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue

FCF/OCF Benchmarks
CompanyFCF/OCF
RCEL : AVITA MEDICAL INC -LUNG : PULMONX CORP -TELA : TELA BIO INC -XTNT : XTANT MEDICAL HOLDINGS INC -168.89%LNSR : LENSAR INC -RPID : RAPID MICRO BIOSYSTEMS INC -SGHT : SIGHT SCIENCES INC -ELMD : ELECTROMED INC 97.7%APYX : APYX MEDICAL CORP -AGEN : AGENUS INC -

Definition of Free Cash Flow to Operating Cash Flow

[Calculation] The Free Cash Flow to Cash Flow from Operations ratio, describes how much of a company’s operating cash flow [NCFO] is free to be invested after capital expenditures [CapEx].
FCF / CF - Operations
(=) FCF/OCF
FCF/OCF for ANIKA THERAPEUTICS INC is calculated as follows: FCF [ $ 22.05M ] / CF - Operations [ $ 23.5M ]
(=) FCF/OCF [ 93.84% ]

ANIK - Free Cash Flow to Operating Cash Flow, Last 5 years

-243.08%

Minimum

Mar 31, 2024

93.84%

Maximum

Sep 30, 2020

-8.77%

Average

26.78%

Median

FCF/OCF Benchmark Analysis

The chart above depicts the distribution of FCF/OCF for companies in the Total Stock Market. The average FCF/OCF of the companies is 71.44% with a standard deviation of 29.12%.
The following table provides additional summary stats:
FCF/OCF in the Market:
filtered constituents2.51K
min-23%
max171.58%
average71.44%
median80.83%
std29.12%